SPHK1 and ovarian endometrioid adenocarcinoma: In the subgroup analysis of endometrioid ovarian cancer (n = 155, 15.4%), low SPHK1 expression was detected more often than high expression (low SPHK1 in 68.4%, high SPHK1 in 31.6%).